TIAN Huiru,JIANG Siqin,LYU Hong,et al.Danshen Injection Inhibits Platelets-induced Metastasisof Breast Cancer Cells In Vitro[J].Chinese Journal of Experimental Traditional Medical Formulae,2023,29(21):79-85.
TIAN Huiru,JIANG Siqin,LYU Hong,et al.Danshen Injection Inhibits Platelets-induced Metastasisof Breast Cancer Cells In Vitro[J].Chinese Journal of Experimental Traditional Medical Formulae,2023,29(21):79-85. DOI: 10.13422/j.cnki.syfjx.20230325.
Danshen Injection Inhibits Platelets-induced Metastasisof Breast Cancer Cells In Vitro
To observe the effect of Danshen injection (DAN) on platelet (PLT)-induced metastasis of breast cancer cells
in vitro
.
Method
2
The 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay was used to observe the effect of DAN on the growth of MDA-MB-231 cells
in vitro
. Oris™ migration assay was used to determine the effect of DAN (final mass concentrations 4, 8, 16 g·L
-1
) on PLT (1.5×10
10
cells/L)-induced migration of breast cancer cells
in vitro
. The effect of DAN on PLT-induced cell invasion was detected by Transwell assay. Immunofluorescence and Western blot were used to detect the effect of DAN on the protein expression associated with PLT-induced epithelial-mesenchymal transition (EMT). In addition, enzyme-linked immune-sorbent assay (ELISA) was used to determine the effect of DAN (final mass concentrations 4, 8, 16, 32, 64 g·L
-1
) on the secretion of transforming growth factor-
β
1
(TGF-
β
1
). Western blot was used to observe the effect of DAN on the expression of podoplanin (PDPN) protein in MDA-MB-231 cells induced by PLT.
Result
2
Compared with the blank group, the DAN groups (32 and 64 g·L
-1
) showed decreased
A
570
(
P
<
0.05,
P
<
0.01), and there was no significant difference in
A
570
between DAN groups (4, 8, 16 g·L
-1
). Compared with the blank group, the PLT group showed increased cell migration and invasion, while DAN groups significantly inhibited PLT-induced cell migration and invasion. Compared with the blank group, the PLT group showed decreased expression of E-cadherin, while DAN could significantly reverse this effect of PLT. Compared with the blank group, the PLT group showed increased Slug and Snail protein expression (
P
<
0.05,
P
<
0.01), while DAN significantly reversed Snail protein expression induced by PLT (
P
<
0.05,
P
<
0.01). The content of TGF-
β
1
in the PLT group increased (
P
<
0.01), while the secretion of TGF-
β
1
induced by PLT decreased in the DAN groups (16, 32, and 64 g·L
-1
) (
P
<
0.05,
P
<
0.01), and the secretion of TGF-
β
1
was not significantly affected in other DAN groups. PDPN protein expression in the PLT group increased (
P
<
0.01), while DAN could significantly inhibit PLT-induced PDPN expression (
P
<
0.01).
Conclusion
2
DAN can inhibit PLT-induced migration, invasion, and EMT of breast cancer cells. The mechanism may be related to the direct action between breast cancer cells and tumor cells by down-regulating PDPN expression and interfering with PLT and has nothing to do with the effect of TGF-
CHO M S,BOTTSFORD-MILLER J,VASQUEZ H G,et al.Platelets increase the proliferation of ovarian cancer cells[J].Blood,2012,120(24):4869-4872.
MARIE P K, FOWLKES N W, AFSHAR-KHARGHAN V, et al. The provocative roles of platelets in liver disease and cancer[J]. Front Oncol, 2021, doi: 10.3389/fonc.2021.643815http://dx.doi.org/10.3389/fonc.2021.643815.
ZHU H, LUO H, SHEN Z, et al. Transforming growth factor-β1 in carcinogenesis, progression, and therapy in cervical cancer[J]. Tumour Biol, 2016,37(6):7075-7083.
CHEN Y, HUANG S, WU B, et al. Transforming growth factor-β1 promotes breast cancer metastasis by downregulating miR-196a-3p expression[J]. Oncotarget, 2017,8(30):49110-49122.
YUAN L, LIU X. Platelets are associated with xenograft tumor growth and the clinical malignancy of ovarian cancer through an angiogenesis-dependent mechanism[J]. Mol Med Rep, 2015,11(4):2449-2458.
ASTARITA J L, ACTON S E, TURLEY S J. Podoplanin: Emerging functions in development, the immune system, and cancer[J]. Front Immunol, 2012,doi: 10.3389/fimmu.2012.00283http://dx.doi.org/10.3389/fimmu.2012.00283.
HWANG B O, PARK S Y, CHO E S, et al. Platelet CLEC2-Podoplanin axis as a promising target for oral cancer treatment[J]. Front Immunol, 2021, doi: 10.3389/fimmu.2021.807600http://dx.doi.org/10.3389/fimmu.2021.807600.
SUZUKI-INOUE K. Roles of the CLEC-2-Podoplanin interaction in tumor progression[J]. Platelets, 2018, doi: 10.1080/09537104.2018.1478401http://dx.doi.org/10.1080/09537104.2018.1478401.
TSUKIJI N,OSADA M,SASAKI T,et al.Cobalt hematoporphyrin inhibits CLEC-2-podoplanin interaction, tumor metastasis, and arterial/venous thrombosis in mice[J].Blood Adv,2018,2(17):2214-2225.
WATANABE N, KIDOKORO M, TANAKA M, et al. Podoplanin is indispensable for cell motility and platelet-induced epithelial-to-mesenchymal transition-related gene expression in esophagus squamous carcinoma TE11A cells[J]. Cancer Cell Int, 2020, doi: 10.1186/s12935-020-01328-2http://dx.doi.org/10.1186/s12935-020-01328-2.